Acorn Regulatory has obtained a Manufacturer’s / Importer’s Authorisation (MIA) licence for Veterinary Use. Find out more here.
Acorn Regulatory Secures Manufacturer’s/Importer’s Authorisation Licence
read more
Blog
Acorn Regulatory News
Search
Categories
Most Read Explainer Articles of 2020
Acorn Regulatory’s website has a wealth of articles that assist regulatory, pharmacovigilance and clinical professionals all over the world. We consistently feature ‘how-to’ and explainer articles. These are the most read ‘how-to’s’ and explainer articles on our website in 2020.
The Northern Ireland Protocol & Medical Devices: Explained
What will be the impact of the Northern Ireland Protocol for medical device companies? We look at the issue in our Northern Ireland Protocol e-book.
How Will The Northern Ireland Protocol Impact Medical Device Companies?
This whitepaper looks at the issues relating to the Northern Ireland Protocol and the medical devices sector and is part of our Brexit series,
How Will The Northern Ireland Protocol Impact Pharma Companies?
How will the Northern Ireland Protocol impact on companies in the pharmaceutical sector? We answer some of the most commonly asked questions.
Do You Need A WDA? Here Is What You Need To Know
If you need a WDA for your company, we can help you to obtain a Wholesale Distribution Authorisation. Contact Acorn Regulatory today.
How to Move from a DCP Close Out To Product Launch
We look at the issue and answer 10 of the most common questions relating to a DCP close-out. Read more here.
Pharmacovigilance KPIs: How They Can Assist You
We have updated this article, one of the most popular on our site. Pharmacovigilance KPIs and how they can assist you. Read the article here.
The Unique Device Identifier system applies new requirements on all participants under MDR. Read the blog and find out more about UDI’s.
What Is A Unique Device Identifier?
The Unique Device Identifier system applies new requirements on all participants under MDR. Read the blog and find out more about UDI’s.
What Are Post-Marketing Surveillance Studies?
We look at post-marketing surveillance studies and the link with Risk Minimisation Plans (RMP’s) in this article.
How To Improve The Readability of Package Leaflets
What changes could be made to the readability of package leaflets to make them more accessible for patients? Eileen Shortiss, a Senior Regulatory Affairs Advisor at Acorn Regulatory is our in-house expert on all matters relating to package information leaflets. She...
How To Fix Common eCTD Validation Issues
Previously, we looked at issues that arise within eCTD. Our Publishing Manager, Eileen Ryan, looks at eCTD validation issues in this article. The article looks at Module 1 specification issues and more. We have outlined some additional guidance on eCTD validation...
The 3 Options for eCTD Publishing & Submission Services
This article looks at the three options open to companies when considering how to manage eCTD publishing & submission within their company.
Pharmacovigilance of Medicines for Rare Diseases
We look at the issue of pharmacovigilance for orphan or rare diseases. You can read the article by clicking here.
The FDA Move from Paper to Electronic DMFs
Since May 2019 the US FDA no longer accepts paper formatted DMF’s. The move from paper to electronic reporting continues.
Veterinary Clinical Trials: New EU Law & Global Approaches
There are several ways to approach and perform veterinary clinical trials. Having multiple investigational sites can help overcome potential bias.
How To Fix Complications with UUID Numbers in eCTD
Acorn Regulatory's publishing team is staffed by eCTD experts. We have assisted many companies in their eCTD projects in recent years. Many visitors to our website submit questions on regulatory issues. Issues with UUID numbers arise time and again and we are...
What You Need To Know About Drug Device Combination Products
This drug device explainer looks at the issues concerning combimation products as the sector moves from the MDD to MDR in 2021.
Moving from MDD to MDR? Here Is What You Need To Know
MDR will come into force in 2021. It differs greatly from the MDD. What will the major changes be for medical device manufacturers, importers, and distributors? We look at the major changes in the move from MDD to MDR in this article. What is the MDR? Medical...
How To Write An Effective CER
The MDR introduced has new, stricter criteria for CER (Clinical Evaluation Reports), such as the basis of establishing an equivalence with another device
Update on the EU Authorised Representative & Brexit
This is a June 2020 update on Brexit and the impact on the EU Authorised Representative in light of the UK’s departure from the EU.
Expectations for Human Use Products During The Covid-19 Pandemic
What guidance has been provided to Marketing Authorisation Holders on regulatory expectations and flexibility during the Covid-19 pandemic?
How To Prepare for Remote Audits
We look at how you can prepare for remote audits that might be carried using a virtual technology tool. Click to read the full article.
Strategy
Subscribe to Our Newsletter
Sign up for our newsletter today and stay informed on the latest regulatory updates and industry insights.